Incidence and survival outcomes of myocarditis and pericardial diseases associated with immune checkpoint inhibitor therapy

Incidence and survival outcomes of myocarditis and pericardial diseases associated with immune checkpoint inhibitor therapy

Abstract Introduction Immune checkpoint inhibitor(ICI) induced cardiac immune related adverse events are challenging to study; Leveraging large data bases like TriNetX global health network may provide needed insights. Methods We performed a retrospective cohort study including patients diagnosed ne...

Full description

Saved in:
Bibliographic Details
Main Authors: Aya F. Ozaki, Michael Sayer, Hirofumi Hamano, Misako Nagasaka, Benjamin J. Lee, Jean Doh, Ali Naqvi, Nareh Nowrouzi, Yoshito Zamami, Pranav M. Patel
Format: Article
Language:English
Published: BMC 2025-03-01
Series:Cardio-Oncology
Subjects:
Immune checkpoint inhibitors
Myocarditis
Cardiotoxicity
Immune-related adverse events
Overall survival
Online Access:https://doi.org/10.1186/s40959-025-00300-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40959-025-00300-1

Similar Items